90983-02-1

Upstream product

• 3496-11-5 2,5-dioxopyrrolidin-1-yl (2S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate 
• 3338-32-7 Z-Asp(OtBu)-OSu 
• 72-18-4 L-valine 
• 98210-50-5 Z-Ser(Bu^t)-Val-OH 
• 98210-49-2 Z-Trp-Val-Gly-Asp(OBu^t)-Lys(Boc)-OBu^t 
• 98210-48-1 H-Val-Gly-Asp(OBu^t)-Lys(Boc)-OBu^t*HCl 
• 98229-44-8 Z-Val-Gly-Asp(OBu^t)-Lys(Boc)-OBu^t 
• 98229-43-7 H-Gly-Asp(OBu^t)-Lys(Boc)-OBu^t*HCl 
• 98229-42-6 Z-Gly-Asp(OBu^t)-Lys(Boc)-OBu^t 
• 98229-41-5 H-Asp(OBu^t)-Lys(Boc)-OBu^t*HCl 
• 98229-40-4 Z-Asp(OBu^t)-Lys(Boc)-OBu^t 
• 98210-51-6 H-Ser(Bu^t)-Val-OH 
• 13288-57-8 1,1-dimethylethyl N₆-{[(1,1-dimethylethyl)oxy]carbonyl}-L-lysinate hydrochloride 
• 19460-97-0 Z-Ser(Bu^t)-ONSu 

Relevant academic research and scientific papers

Synthesis of the Hypothetical Active Site of the Nerve Growth Factor

The synthesis of an unsymmetrical cystine peptide corresponding to the sequence 10-25/75-88 of mouse nerve growth factor was performed via the newly developed sulfenohydrazide procedure.The triacontapeptide isolated at a high degree of purity after Sephadex-LH 20 chromatography, did not exhibit in the biological assays the expected nerve growth factor activity as reported by Revoltella and coworkers. - Keywords: Nerve growth factor; Peptide synthesis; Unsymmetrical cystine peptides